Condition: Children Born to Mothers Enrolled in the TOCOPROM Trial · Sponsor: Assistance Publique - Hôpitaux de Paris
The purpose of this study is to evaluate the neurodevelopment at age 6 of children born to women with preterm prelabor rupture of membranes at 22 to 33 weeks of gestation, after antenatal exposure to nifedipine vs placebo.
This description comes directly from the study's public registry record.
Gilles KAYEM, MD,PhD · 01 44 73 51 18 · gilles.kayem@aphp.fr
Nelly Briand, PhD · 01 44 38 18 62 · nelly.briand@aphp.fr
Always discuss trial participation with your own doctor first.
| Trousseau University Hospital | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07146451